Tekmira Pharmaceuticals Completes Merger with OnCore Biopharma

Tekmira Pharmaceuticals Corporation

Represented Tekmira Pharmaceuticals Corporation (now Arbutus Biopharma) (Nasdaq:ABUS) in connection with its merger with OnCore Biopharma, Inc.

Arbutus Biopharma is a biopharmaceutical company dedicated to discovering, developing and commercializing a cure for patients suffering from chronic hepatitis B infection. *





* indicates transactions initiated at prior firms.